West Coast Laboratories Inc recalls Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
- Recall date
- January 11, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- F-1430-2017
- FDA classification
- Class II
- Brand / firm
- West Coast Laboratories Inc
- Sold / distributed
- Colombia, South America
Why it was recalled
West Coast Laboratories is recalling Xambo and Devagrass because there may be presence of 1,3-dimethylamylamine (DMAA).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Xambo, 80 boxes of bulk capsules. Each containing 12,053 capsules in each box.
Get recall alerts
Free email alert whenever West Coast Laboratories Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: West Coast Laboratories Inc